The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis.

The Journal of investigative dermatology 2023 Oct

filter terms:

APOA-1 is central to the high-density lipoprotein function of reverse cholesterol transport measured by cholesterol efflux capacity. Psoriasis is a systemic inflammatory disease associated with poor cholesterol efflux capacity and accelerated noncalcified coronary burden (NCB) as measured by coronary computed tomographic angiography. In this study, we characterized the relationship between APOA-1, cholesterol efflux capacity, and progression of NCB over 4 years. Consecutively recruited participants with psoriasis underwent coronary computed tomographic angiography for NCB quantification (Medis QAngio, Leiden, The Netherlands) at baseline (n = 310) and at four years (n = 124). Blood was assessed for cardiometabolic biomarkers. The lowest quartile of APOA-1 was associated with cardiometabolic blood markers (insulin, homeostatic model assessment for insulin resistance, and cholesterol efflux capacity) and higher NCB (P < 0.001). The low APOA-1 quartile had higher NCB at 4 years (β = -0.36, P = 0.02) in fully adjusted models. Finally, a 10-unit decrease of APOA-1 was associated with a 16% increase in NCB progression over 4 years (OR = 0.83, 95% confidence interval = 0.70-0.99, P = 0.04). In addition to being associated with cardiometabolic disease, low APOA-1 was associated with more NCB over time. These findings show that low APOA-1 is correlated with initiation and progression of coronary artery disease and may have clinical utility in identifying high-risk populations for development of cardiovascular disease. Published by Elsevier Inc.

Citation

Heather L Teague, Haiou Li, Alexander R Berg, Christin Hong, Rylee F Petrole, Ross O'Hagan, Elizabeth M Florida, Andrew Keel, Justin Rodante, Promita Kapoor, Alvaro Gonzalez-Cantero, Alexander V Sorokin, Aditya Joshi, Nidhi Patel, Joel M Gelfand, Martin P Playford, Nehal N Mehta. The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis. The Journal of investigative dermatology. 2023 Oct;143(10):1947-1954.e4